(Q44005950)

28 November 2017

The low dose dexamethasone suppression test: effect of time of administration and dose (English)

1 reference

dexamethasone suppression test

28 November 2017

0 references

1 reference

C Barton

1

1 reference

PubMed ID

12030615

28 November 2017

S March

series ordinal

2

1 reference

PubMed ID

12030615

28 November 2017

G A Wittert

series ordinal

3

1 reference

28 November 2017

1 April 2002

1 reference

Journal of Endocrinological Investigation

28 November 2017

1 reference

28 November 2017

25

1 reference

28 November 2017

4

1 reference

28 November 2017

RC10-2

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03344008

28 November 2017

0 references

cites work

Evidence for the low dose dexamethasone suppression test to screen for Cushing's syndrome--recommendations for a protocol for biochemistry laboratories

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF03344008

Cushing's syndrome: A review of diagnostic tests

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF03344008

Disrupted 24-hour Patterns of Cortisol Secretion in Psychotic Depression

21 January 2018

1 reference

12 December 2020

The dexamethasone suppression test and thyrotropin-releasing hormone stimulation test in posttraumatic stress disorder

1 reference

12 December 2020

Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.

1 reference

12 December 2020

Psychoneuroendocrine research in depression

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03344008

1 reference

28 November 2017

1 reference

PubMed ID

12030615